Scientific Day 2025

Watch the replays and discover Epicentre's latest studies!
Find out more

Discover our current projects

on Ebola, COVID19, HIV, tuberculosis, malaria, Lassa fever, cholera, nutrition...
Find out more

Our mission

Field epidemiology, research projects and training sessions in support of MSF.
Find out more

Measle

An update on the latest studies conducted by Epicentre to combat this infectious disease
Find out more
Field epidemiology activities, research projects and training sessions in support of Médecins sans frontières
Field epidemiology activities, research projects and training sessions in support of Médecins sans frontières

Latest news

Bannière
DRC ©Newsha Tavakolian
News

Why sex, gender and pregnancy data are essential in times of epidemics?

Published on 20.01.2025
Bannière
Hepatitis E Bentiu, South Sudan
News

Hepatitis E Vaccine: Efficacy of a two-dose regimen and safety for pregnant women confirmed by real-life study

Published on 10.01.2025
Bannière
CAD Tuberculose Philipinnes
News

Enhancing Tuberculosis Diagnosis with AI: Insights from a Study in Manila, Philippines

Published on 17.12.2024
see all

Latest publications

Safety of 3-month rifampicin-isoniazid TPT in child household contacts in a community-based intervention.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2025 Feb 01; 29(2); . doi: 10.5588/ijtld.24.0311. Epub 2025 02 01
Published on

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.

The Lancet. Child & adolescent health 2025 Feb ; 9(2); . doi: 10.1016/S2352-4642(24)00330-4. Epub 2025 01 24
Published on

Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.

The New England journal of medicine 2025 Jan 30; 392(5); . doi: 10.1056/NEJMoa2400327. Epub 2025 01 29
Published on

Beyond COVID-19, the case for collecting, analysing and using sex-disaggregated data and gendered data to inform outbreak response: a scoping review.

BMJ global health 2025 Jan 19; 10(1); . doi: 10.1136/bmjgh-2024-015900. Epub 2025 01 19
Published on
see all

Discover our training courses

Transmitting and transferring epidemiological knowledge is an integral part of Epicentre's mission. Training courses are provided throughout the year to MSF staff and beyond.

Find out more